Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Roan Holdings Group Co., Ltd. Announces Appointment of Junfeng Wang as Chairman, Zhigang Liu Resigns from His Position as Chairman of the Board Due to Personal Reasons 2021-08-13 01:12
Diabetes treatment lowers PromarkerD risk score for diabetic kidney disease 2021-08-12 21:30
Bon Natural Life Limited Announces 2021 Half-Year Earnings Release Date and Webcast 2021-08-12 21:00
WuXi AppTec Reports Strong 2021 Interim Results 2021-08-12 17:52
NUHS Embarks on Holomedicine Research in Singapore, Using Mixed Reality Technology to Enhance Diagnosis, Education and Patient Care 2021-08-12 15:00
Cali Biosciences Initiates Phase 2b Study of Long-Acting Ropivacaine for Non-Opioid Treatment of Post-Operative Pain 2021-08-12 10:28
VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update 2021-08-12 04:10
Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy 2021-08-11 23:00
ImmVira's MVR-T3011 IV Completed First Dosing for Intravenous Administration in a U.S. Phase I Clinical Trial 2021-08-11 10:45
InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP in China 2021-08-11 08:00
Belief Biomed's Gene Therapy for Hemophilia B Receives NMPA IND Approval: First Intravenous Infusion Gene Therapy for Rare Disease in China 2021-08-10 23:39
INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization from the U.S. Food and Drug Administration 2021-08-10 22:00
New Benchmark Report Reveals That Australian Healthcare Websites Are Falling Behind 2021-08-10 06:00
111 to Announce Second Quarter 2021 Unaudited Financial Results on August 27, 2021 -Conference Call to Follow 2021-08-09 19:30
Insightec Announces Seoul National University Hospital Is Installing Exablate Neuro Platform 2021-08-09 08:00
NUH's Smallest Surviving Baby Discharged Well to Home 2021-08-07 15:00
FibroBiologics Announces Inaugural Board of Directors 2021-08-06 22:01
ImmVira's MVR-T3011 Obtained NMPA's Approval for Intravenous Administration (IV) Phase I Clinical Trial 2021-08-06 19:50
Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China 2021-08-06 09:39
China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval 2021-08-05 21:00
1 169 170 171 172 173 766